IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

This study has been completed.
Sponsor:
Collaborator:
Umanis
Information provided by:
Immutep S.A.
ClinicalTrials.gov Identifier:
NCT00349934
First received: July 7, 2006
Last updated: January 6, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
No publications provided by Immutep S.A.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):